City State Bank’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.64M Sell
8,602
-145
-2% -$24.9K 0.37% 62
2026
Q1
$1.48M Buy
8,747
+165
+2% +$28.2K 0.38% 62
2025
Q4
$1.45M Buy
8,582
+889
+12% +$144K 0.4% 59
2025
Q3
$1.11M Buy
7,693
+13
+0.2% +$1.77K 0.32% 65
2025
Q2
$972K Sell
7,680
-610
-7% -$74.9K 0.3% 69
2025
Q1
$1.06M Sell
8,290
-135
-2% -$18.3K 0.35% 63
2024
Q4
$1.11M Sell
8,425
-95
-1% -$13.4K 0.39% 54
2024
Q3
$1.24M Buy
8,520
+25
+0.3% +$3.62K 0.45% 50
2024
Q2
$1.17M Sell
8,495
-16
-0.2% -$2.14K 0.48% 51
2024
Q1
$1.17M Buy
8,511
+177
+2% +$24.2K 0.52% 49
2023
Q4
$1.13M Sell
8,334
-214
-3% -$26.1K 0.57% 45
2023
Q3
$1.04M Buy
8,548
+20
+0.2% +$2.54K 0.58% 45
2023
Q2
$1.08M Sell
8,528
-443
-5% -$57.5K 0.58% 42
2023
Q1
$1.16M Sell
8,971
-95
-1% -$12.4K 0.66% 38
2022
Q4
$1.19M Buy
9,066
+110
+1% +$14.2K 0.73% 33
2022
Q3
$1.05M Sell
8,956
-181
-2% -$22.5K 0.73% 31
2022
Q2
$1.07M Buy
9,137
+445
+5% +$52.8K 0.75% 30
2022
Q1
$1.13M Buy
8,692
+2,281
+36% +$297K 0.68% 34
2021
Q4
$978K Buy
+6,411
New +$993K 0.6% 46

Other funds holding IBB

City State Bank's IBB Position: Q2 2026 in Review

City State Bank reduced its iShares Biotechnology ETF (IBB) stake by 1.7% in Q2 2026, selling an estimated $24.9K and leaving 8,602 shares worth $1.64M. The position accounts for 0.37% of the portfolio, ranked #62.

City State Bank first reported a position in IBB in Q4 2021 and has held it in 19 quarters since. 421 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • City State Bank held 8,602 shares of iShares Biotechnology ETF worth $1.64M as of Q2 2026.
  • City State Bank sold 145 iShares Biotechnology ETF shares in Q2 2026, an estimated $24.9K.
  • iShares Biotechnology ETF made up 0.37% of City State Bank's portfolio in Q2 2026, its #62 holding.
  • City State Bank first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 19 quarters since.
  • 421 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on City State Bank's 13F filing for Q2 2026, filed 14 Jul 2026.